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Aging research has been very successful at identifying signaling
pathways and evolutionarily conserved genes that extend lifespan
with the assumption that an increase in lifespan will also increase
healthspan. However, it is largely unknown whether we are ex-
tending the healthy time of life or simply prolonging a period of
frailty with increased incidence of age-associated diseases. Here we
use Caenorhabditis elegans, one of the premiere systems for lifespan
studies, to determine whether lifespan and healthspan are intrinsi-
cally correlated. We conducted multiple cellular and organismal
assays on wild type as well as four long-lived mutants (insulin/
insulin-like growth factor-1, dietary restriction, protein translation,
mitochondrial signaling) in a longitudinal manner to determine the
health of the animals as they age. We find that some long-lived
mutants performed better than wild type when measured chrono-
logically (number of days). However, all long-lived mutants increased
the proportion of time spent in a frail state. Together, these data
suggest that lifespan can no longer be the sole parameter of interest
and reveal the importance of evaluating multiple healthspan para-
meters for future studies on antiaging interventions.
healthspan | lifespan | gerospan | functional capacity | healthy aging
Advances in technology, healthcare, and nutrition have con-siderably increased the average life expectancy worldwide.
In addition, lower birthrates in developed countries along with
a decline in the adult mortality rate have led to an increase in the
number of older individuals worldwide. According to the World
Health Organization, the population of people living 85 y and
beyond is predicted to increase by 351% globally in the next 40 y
(1). Because aging is accompanied by an increased incidence of
many diseases including cancer, arthritis, obesity, and diabetes,
the majority of healthcare costs are associated with the last few
years of life, which could lead to an economic disaster (2). One
possible solution could involve aging research focused on in-
creasing the health of the aging population (3).
Over the last two decades, aging research has focused on
lifespan regulation with little attention to the health of the ani-
mal. Studies with model systems such as yeast, worms, and flies
have identified hundreds of different genes, regimens, and
chemicals that modulate lifespan. Many of these life-extending
treatments are also conserved in mammals (4, 5). In the nema-
tode Caenorhabditis elegans (C. elegans), multiple pathways in-
cluding insulin/insulin-like growth factor (IGF)-1 signaling,
dietary restriction, altering mitochondrial signaling, and protein
translation modulate mean and maximal lifespan (6–11). Life-
span has been considered the ultimate parameter, defined as the
period an organism survives. The common assumption that
treatments, which increase lifespan, would prolong health or
healthspan is supported by previous studies that suggest
a correlation between increased stress resistance and lifespan
extension (12–17). However, these studies have been limited by
only testing animals at younger ages; older animals have rarely
been examined.
In C. elegans, age-associated phenotypes such as changes in
movement capacity have had conflicting results about whether
movement decline correlates with lifespan (18, 19). Another se-
ries of C. elegans studies suggests that some life-extending treat-
ments improve cognitive function, including performance and
memory function, whereas others do not (20, 21). In Drosophila,
dietary-restricted flies show lifespan extension but no improve-
ment in their cognitive ability (aversion learning test) compared
with wild type (22). In another study, dietary restriction did not
provide functional benefits to older flies (23). Finally, flies exposed
to different concentrations of the anticonvulsant lamotrigine,
known to increase the lifespan of worms, reduced movement ca-
pacity significantly as the flies aged, suggesting that lifespan ex-
tension led to an increase in frailty (24). Together, these data show
the importance of further dissecting the connection between
lifespan and healthspan.
Although the term lifespan is well-defined, there is no single,
generally accepted definition of health or healthspan. In a clini-
cal setting, the term most commonly used to predict age-related
mortality is the frailty index (FI). FI is defined per individual as
the proportion of deficits present out of the total number of age-
related health variables, which broadly covers self-sufficiency and
disease-free state in human beings (25, 26). In the laboratory, as
mentioned above, several studies have examined physiological
changes with age (19, 27, 28). The term healthspan is poorly
defined and, in C. elegans, few parameters such as movement,
pharyngeal pumping (feeding), and lipofuscin accumulation
(29–33) have been measured as healthspan parameters as the
animals age. There has yet to be a comprehensive definition of
healthspan in the laboratory.
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Here we broadly define healthspan by measuring multiple
physiological parameters over the life of the worm (SI Appendix,
Fig. S1). Our healthspan study has many important aspects,
which include that (i) we measured healthspan using a large
number of assays, (ii) we tested animals in multiple assays until
∼80% of the population had died, and (iii) we calculated and
compared the health of the different strains in two different ways:
chronological (actual day) and physiological (as a percentage of
maximal lifespan: allowing the determination of the percentage of
healthy and frail periods of the entire lifespan of the animal).
Taken together, our healthspan assays cover an FI as well as ad-
ditional assays, including the ability to maintain homeostasis in
response to external stress, movement, lipofuscin accumulation
and feeding (pharyngeal pumping), and other cellular changes
(SI Appendix, Fig. S1B).
Results
We tested four different long-lived mutants in this study,
daf-2(e1370), eat-2(ad1113), ife-2(ok306), and clk-1(qm30) [daf,
abnormal dauer formation; eat, abnormal pharyngeal pumping;
ife, initiation factor 4E (eIF4E) family; clk, (biological timing)
abnormality], where each represent a different signaling pathway
(insulin/IGF-1 signaling, dietary restriction, protein translation
and mitochondrial signaling respectively) implicated in lifespan
regulation. Fig. 1 shows lifespan analysis for all four mutants
compared with wild type. All of the mutations result in increased
mean and maximal lifespan compared with wild type (Fig. 1 and
SI Appendix, Fig. S2). daf-2(e1370) mutants, the canonical allele
most routinely used, bear a mutation in the insulin/IGF-1 re-
ceptor that results in a doubling of lifespan (maximal lifespan of
57 d compared with 30 d for wild type) (6).
Dietary restriction is an environmental intervention proven to
increase lifespan in animals ranging from yeast to mammals (34–
36). In C. elegans, at least seven different methods have been
standardized to induce dietary restriction (37). Here we use the
genetic model of dietary restriction in worms, eat-2, which has
a maximal lifespan of 36 d, resulting in a 20% increase in lifespan
compared with wild type (Fig. 1). These mutants have reduced
feeding capacity due to a defective protein encoding the nicotinic
acetylcholine receptor subunit that functions in the pharyngeal
muscle to regulate the rate of pharyngeal pumping (38). There-
fore, eat mutants have reduced food uptake, serving as a model of
dietary restriction.
In C. elegans, modulating mitochondrial activity by the mutation
of genes involved in electron transport chain activity is also known
to increase lifespan. One of the genes, clk-1, results in mean and
maximum lifespan extension in worms of 25% and 10%, re-
spectively (Fig. 1) (8). The clk-1 gene encodes an enzyme (deme-
thoxyubiquinone monooxygenase) necessary for ubiquinone
biosynthesis required during respiration for shuttling electrons from
complex I and II to complex III (39). A heterozygous knockout of
mclk-1 in mice, the mammalian homolog of C. elegans clk-1, has
reduced reactive oxygen species (ROS) levels, decreased ROS
sensitivity, and ROS damage along with increased lifespan (39).
The fourth signaling cascade that modulates longevity in inver-
tebrate models is the regulation of translation in the somatic tissues
(9–11). These regulators include kinases that signal to promote
mRNA translation, translation initiation factors, structural compo-
nents of the ribosome, and ribosomal RNA processing factors. The
eukaryotic initiation factor 4E (eIF4E) is a key modulator of pro-
tein translation because eIF4E binds the 7-monomethylguanosine
cap at the 5′ end of nuclear mRNAs (40). To serve as a model for
protein translation, we used the gene ife-2. Knockdown of ife-2, the
C. elegans isoform of eIF4E, increases maximal lifespan to 42
d compared with 30 d in wild type (Fig. 1) (9). In mice, inhibition of
mammalian target of rapamycin, a key regulator of mRNA trans-
lation in response to nutrients, can also result in lifespan extension
(41). In this study, we measured the health of different long-lived
mutants to determine whether a meaningful increase in lifespan
also translates into improved healthspan.
Next, the mortality curves from Fig. 1A were modeled with the
commonly used Gompertz equation following the analysis of
Yen et al. (42). Gompertz analysis is based on the observation
that the mortality rate increases exponentially with time after
middle age. It is represented by the equation S = AeGt, where S is
the mortality rate, A is the initial mortality rate calculated from
the mortality rate before the exponential increase in deaths with
age in a population, and G is the exponential (Gompertz) mortality
rate coefficient.
The Gompertz variable is used to determine the rate of aging
based on the calculation of the mortality rate doubling time
(MRDT) given by MRDT = 0.693/G. For example, if a pop-
ulation of worms has an MRDT of 10 d, it signifies that the
chance of those worms dying after sexual maturity doubles ap-
proximately every 10 d. Therefore, a lower value of G would
indicate a higher MRDT and a slower rate of aging. Our data
reveal that, compared with wild type, both daf-2 and clk-1
mutants had significant decreases in initial mortality rate and
daf-2, eat-2, and ife-2 had a significant decrease in the Gompertz
variable as determined by the likelihood ratio test (Table 1). In
terms of the aging rate, daf-2, eat-2, and ife-2 decrease the value
of the Gompertz variable, thereby reducing MRDT.
Because the Gompertz analysis only compares survival data, the
rate of aging defined by this equation is limited; it gives no in-
formation on the health changes of the aging animal. Therefore, we
Genotype Mean 
Lifespan
(days)
% Increase 
in Mean 
Lifespan
Maximum 
Lifespan
(days)
% Increase 
in Maximum 
Lifespan
Wild type 20.0±0 30.0±0
daf-2(e1370) 43.0±0 115.0% 57.0±0 90.0%
ife-2(ok306) 29.0±1.4 40.0% 42.5±0.7 41.6%
clk-1(qm30) 25.0±0 25.0% 33.5±2.1 10.0%
eat-2(ad1113) 26.5±2.1 32.5% 36.0±0.7 20.0%
Genotype Initial Mortality Rate 
(A)
Gompertz
Value (G)
Wild type 6.57E-04 2.53E-01
daf-2(e1370) 2.04E-04 1.43E-01
ife-2(ok306) 1.11E-03 1.49E-01
clk-1(qm30) 2.27E-04 2.56E-01
eat-2(ad1113) 4.81E-04 2.10E-01
A
B
C
Fig. 1. Survival analysis of the strains used in the study. (A) Survival curve of
all strains used in this study: wild type (black), daf-2(e1370) (blue), eat-2
(ad1113) (purple), ife-2(ok306) (orange), and clk-1(qm30) (yellow). (B) All
strains have different mean and maximal lifespan and show differences
compared with wild type. (C) Gompertz analysis based on the mortality rate
of the mutant strains compared with wild type. A, initial mortality rate; G,
Gompertz variable. The values were derived from the survival curves. A
lower G value indicates a slower aging rate.
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examined the health of wild type as well as different long-lived
mutants by testing multiple parameters as the animals age. We
then determined whether the rate of change in the different
health parameters correlated with the prediction of the rate of
aging based on the mortality curves.
Changes in Capacity to Maintain Homeostasis with Age.Aging involves
the systemic loss of ability to recover from internal and external
stresses in older people (43). We reasoned that healthy aged ani-
mals should have the ability to maintain homeostasis, which is
defined as the ability to respond to physiological perturbations.
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Fig. 2. Resistance to heat stress decreases with age. Each graph represents a different long-lived mutant compared with wild type. The bar graph shows the
average of the mean survival time under heat stress for a population of aging animals for two biological repeats, plotted on the primary (left) y axis. The
dotted lines represent the percent survival of the individual strains (lifespan analysis), plotted on the secondary (right) y axis. Wild type is shown in each graph
as gray bars and gray triangles. (Upper Left) daf-2(1370), blue bars and open circles. (Upper Right) ife-2(ok306), orange bars and open squares. (Lower Left)
clk-1(qm30), yellow bars and open diamonds. (Lower Right) eat-2(ad1113), pink bars and open triangles. For all strains, resistance to heat was measured for
different ages of each strain until 80% of the animals were dead and declines with age. At day 1, compared with wild type, clk-1, ife-2, and eat-2 mutants
were sensitive to heat stress whereas daf-2 mutants were resistant. Compared with wild type, when analyzed chronologically, clk-1, ife-2, and daf-2 mutants
show a similar rate of decline whereas eat-2 mutants show a faster rate of decline in oxidative stress resistance capacity. Compared with wild type, when
analyzed physiologically, clk-1 and eat-2 mutants show a faster rate of decline whereas ife-2 and daf-2 mutants show a similar rate of decline in heat stress
resistance capacity (see text for additional details). Error bars represent SE from two biological repeats.
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Fig. 3. Resistance to oxidative stress decreases with age. Each graph represents a different long-lived mutant compared with wild type. The bar graph shows
the average of the mean survival time under oxidative stress for a population of aging animals for two biological repeats, plotted on the primary (left) y axis.
The dotted lines represent the percent survival of the individual strains (lifespan analysis), plotted on the secondary (right) y axis. Wild type is shown in each
graph as gray bars and gray triangles. (Upper Left) daf-2(1370), blue bars and open circles. (Upper Right) ife-2(ok306), orange bars and open squares. (Lower
Left) clk-1(qm30), yellow bars and open diamonds. (Lower Right) eat-2(ad1113), pink bars and open triangles. For all strains, oxidative stress resistance was
measured for different ages of each strain until 80% of the animals were dead and declines with age. Compared with wild type chronologically, daf-2
mutants are more resistant to oxidative stress whereas ife-2 and clk-1 mutants are more sensitive to oxidative stress. Chronologically, compared with wild
type, eat-2, ife-2, and daf-2mutants show a similar rate of decline whereas clk-1mutants have a slower rate of decline in oxidative stress resistance. Compared
with wild type physiologically (age-matched population), ife-2 and clk-1mutants show a similar rate of decline whereas daf-2 and eat-2mutants show a faster
rate of decline in oxidative stress resistance capacity (see text for additional details). Error bars represent SE from two biological repeats.
Bansal et al. PNAS | Published online January 5, 2015 | E279
G
EN
ET
IC
S
PN
A
S
PL
U
S
Therefore, the first set of assays tested was the response to heat
stress and oxidative stress. Because these assays were terminal,
a representative set of aging animals was tested every fifth day. For
all of the assays, we tested wild type as well as the four long-lived
mutants, namely daf-2(e1370), eat-2(ad1113), ife-2(ok306), and
clk-1(qm30).
0
20
40
60
80
100
0
1
2
3
4
5
6
7
8
9
10
1 5 10 15 20 25 30 35 40 42
Pe
rc
en
t s
ur
vi
va
l
D
is
ta
nc
e 
m
ov
ed
Days
0
20
40
60
80
100
0
1
2
3
4
5
6
7
8
9
10
1 5 10 15 20 25 30 35
Pe
rc
en
t s
ur
vi
va
l
D
is
ta
nc
e 
m
ov
ed
Days
0
20
40
60
80
100
0
1
2
3
4
5
6
7
8
9
10
1 5 10 15 20 25 30 35 40 45 50 55 57
Pe
rc
en
t s
ur
vi
va
l
D
is
ta
nc
e 
m
ov
ed
Days
0
20
40
60
80
100
0
1
2
3
4
5
6
7
8
9
10
1 5 10 15 20 25 30 35 40
Pe
rc
en
t s
ur
vi
va
l
D
is
ta
nc
e 
m
ov
ed
Days
daf-2(e1370) ife-2(ok306)
clk-1(qm30) eat-2(ad1113)
Fig. 4. Movement capacity of worms: distance traveled on solid media. Each graph represents a different long-lived mutant compared with wild type. The
bar graph shows the average distance traveled on solid media plates for each age plotted on the primary (left) y axis. An average of 15 worms was singled
onto seeded NGM plates and allowed to move for 5 min. The distance traveled was measured (arbitrary units) and compared with wild type (gray filled bars).
The dotted lines represent the percent survival of the individual strains (lifespan analysis), plotted on the secondary (right) y axis compared with wild type
(gray triangles). Each graph represents a different long-lived mutant compared with wild type (gray bars and gray triangles). (Upper Left) daf-2(1370), blue
bars and open circles. (Upper Right) ife-2(ok306), orange bars and open squares. (Lower Left) clk-1(qm30), yellow bars and open diamonds. (Lower Right) eat-
2(ad1113), pink bars and open triangles. For all strains, the distance moved was measured for different ages of each strain until 80% of the animals were dead
and declines with age. Compared with wild type, at day 1, eat-2mutants cover significantly less distance whereas clk-1, daf-2, and ife-2mutants move a similar
distance. Chronologically, compared with wild type, daf-2 mutants’ movement capacity (distance) declined at the same rate, clk-1 and ife-2 mutants lost their
movement capacity at a slower rate, and eat-2mutants had a faster rate of decline. Physiologically (age-matched populations), compared with wild type, daf-2
and clk-1 mutants declined at the same rate, whereas ife-2 and eat-2 mutants lost their movement capacity faster (see text for additional details).
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Fig. 5. Movement capacity of aging worms: movement in liquid media. Each graph represents a different long-lived mutant compared with wild type. The
bar graph indicates the average thrashings per minute for each age (15 animals total) plotted on the primary (left) y axis. The worms were transferred to M9
media and allowed to move in the liquid. The number of thrashes per minute was counted and then plotted. The dotted lines represent the percent survival
of the individual strains (lifespan analysis), plotted on the secondary (right) y axis compared with wild type (gray triangles). Each graph represents a different
long-lived mutant compared with wild type (gray bars and gray triangles). (Upper Left) daf-2(1370), blue bars and open circles. (Upper Right) ife-2(ok306),
orange bars and open squares. (Lower Left) clk-1(qm30), yellow bars and open diamonds. (Lower Right) eat-2(ad1113), pink bars and open triangles. For all
strains, movement was measured for different ages of each strain until 80% of the animals were dead and declines with age. Compared with wild type
chronologically, daf-2 mutants thrash significantly less initially whereas clk-1 mutants move similar to wild type. The rate of decline in thrashing capacity is
faster than wild type until young/midlife and then slows down at older age. When compared chronologically to wild type, the rate of decline is higher for eat-2
mutants and slower for ife-2 mutants. Compared with wild type physiologically, daf-2, clk-1, and eat-2 mutants show a faster rate of decline in movement
capacity whereas for ife-2 mutants, movement capacity declines at the same rate.
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For heat stress, every fifth day, plates were transferred to
37 °C and the population was assayed for their response.
Consistent with previous studies (44), young daf-2mutants were
resistant to heat stress compared with wild type (P < 1e-16)
(Fig. 2). However, at day 1, the other long-lived mutants—the
dietary restriction mutant eat-2 and the protein translation
mutant ife-2—were sensitive to heat stress (P < 0.05), whereas
clk-1 showed similar survival under heat stress compared with
wild type (Fig. 2).
For oxidative stress, worms were transferred onto plates con-
taining paraquat and the survival time was recorded. Initially,
daf-2(e1370)mutants were resistant to oxidative stress (P < 1e-16)
compared with wild type, whereas the other long-lived
mutants showed higher sensitivity to paraquat (Fig. 3). Expect-
edly, for all of the strains, as the animals aged, stress resistance
declined (P < 0.001), indicated by the gradual decrease in mean
survival time under either heat or oxidative stress conditions.
Changes in Movement Capacity with Age. Another hallmark of
human aging is sarcopenia, whereby skeletal muscle shows de-
generative loss of mass, quality, and strength with age (45).
Several C. elegans studies have observed sarcopenia in aging
worms (27, 46, 47). This is seen as a reduction in cell size, loss of
myofibrils, an increase in disorganization, and loss of nicely
packed parallel structures of the myofibrils in worms (27, 47). In
addition, similar to humans, a common feature of aging worms is
reduced muscle function and mobility (18, 47, 48). Therefore, to
further define health, we examined the changes in the movement
capacity of aging wild-type and long-lived animals.
We tested the ability of animals to move in two different ways:
on solid media and in liquid media. For movement on solid
media, we measured the distance traveled over a finite period,
which has previously been suggested to correlate with lifespan
(19). As expected and consistent with previous reports (18, 19,
27), the total distance traveled on solid media decreased with age
for all of the strains (P < 2e-16) (Fig. 4). As shown in Fig. 4, daf-2
mutants move better than wild type from day 10 to day 20,
whereas the other long-lived mutants move similar to wild type.
The second method to assess the movement ability of aging
worms was movement in liquid media (also known as swimming
or thrashing) calculated by the number of body bends for an
individual animal per minute. This differs from movement on
solid media, because the worms are forced to move and the
lateral body movement or thrashing of the animal is counted. We
video-recorded the animals in the liquid media and then counted
the number of thrashes per minute. Similar to the other assays,
for all mutants, the thrashing rate declined with age. In-
terestingly, the animals lost their ability to thrash much earlier
than movement on solid media (Fig. 5). In addition, many ani-
mals showed an uncoordinated movement pattern (Movies S1–
S5) that increased with age irrespective of genotype. It is possible
that this phenotype is associated with altered neuronal signaling
(27) or neuronal aging (49, 50), which also do not correlate with
lifespan or changes in the neuromuscular junction (51).
Next, we examined whether the changes in movement capacity
could be due to the loss of muscle fiber structure. Phalloidin binds
to actin in muscle fibers, and therefore we used phalloidin staining
to examine the muscle structure of the aging animals (52). Worms
were grown and collected at four different time points (day 1, 5,
10, 15) and then fixed and stained with phalloidin (SI Appendix,
Fig. S3). SI Appendix, Fig. S3 shows an example of the phalloidin
staining for all strains at day 15. All of the animals show visible
signs of muscle degradation, as evidenced by a reduction in muscle
cell size, loss of parallel fibers, and increased disorganization.
Then, we examined whether this muscle degradation correlated
with lifespan as previously suggested (27). However, similar to our
results in the movement assays, both wild type and the long-lived
mutants showed similar signs of muscle fiber disorganization de-
spite the differences in lifespan of these five strains: day 15 rep-
resents 50% maximal lifespan for wild type; 26% maximal lifespan
for daf-2; 40% maximal lifespan for eat-2; 35% maximal lifespan
for ife-2; and 44% maximal lifespan for clk-1. This suggests that
the early loss of motility observed in the long-lived animals may be
attributed to the collapse of the muscle fibers themselves.
To feed, worms use a neuromuscular organ called the pharynx
that contracts, allowing food to be ingested and then ground for
use as an energy source. The rate of pharyngeal contraction, also
known as pharyngeal pumping, is regulated to adapt to the
amount and quality of food (53). Pharyngeal pumping declines
with age (19). It has been suggested that this is due to two major
reasons: the increased growth of bacteria in the pharynx as the
animals age that leads to bacterial plugging, and/or the decline in
the structure due to constant muscle contractions and age-
associated degeneration of muscle structure (19, 27). Therefore,
previous studies have used pharyngeal pumping as a marker of
healthspan in C. elegans. We recorded and counted the frequency
of pharyngeal pumping every fifth day as the animals aged.
However, after day 15, irrespective of the genotype, animals
showed little or no pumping (Fig. 6). Because the objective of this
study was to evaluate the effect of the life-extending mutations
in older animals, pharyngeal pumping cannot be considered as
a healthspan parameter. Our results also suggest that the long-
lived animals do not provide protection from the age-related loss
of pumping capacity. Similar to our results, Chow et al. (48) ob-
served little or no pharyngeal pumping after day 12 of adulthood.
Fig. 6. Pharyngeal pumping of aging worms. The bars represent the number
of pharyngeal contractions per minute. Pumping rate declines with age for all
of the strains until day 15. After day 15, all strains show negligible pumping.
Error bars represent the SE for each strain (n = 10).
Table 1. Summary of the rate of decline in different health parameters when compared
physiologically or age-matched populations
Genotype Heat stress resistance Oxidative stress resistance Distance moved Thrashing in liquid
daf-2 >WT >WT =WT >WT
eat-2 >WT >WT >WT >WT
ife-2 >WT =WT >WT =WT
clk-1 >WT =WT =WT =WT
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Autofluorescence/Lipofuscin Accumulation. Another conserved phe-
nomenon observed to change with age is the accumulation of the
age-related fluorescent pigments or lipofuscin granules, which
are the waste products that accumulate in the lysosomal cells
(54). Even though the role of such pigments is unclear, lipofuscin
visualization is often used as an age-related marker and a quan-
tifier of healthspan in C. elegans. Therefore, we quantified this
fluorescence with age (Fig. 7). Both long-lived mutants daf-2 and
ife-2 showed significantly (P < 0.05) reduced age-associated gran-
ules compared with wild type at day 1 and day 15. However, after
day 15, the amount of accumulated lipofuscin was not significantly
different between any of the long-lived strains (Fig. 7). Given that
all of the strains show different mean lifespan, these data suggest
that although lipofuscin accumulation changes with age, the in-
creased levels do not correlate with lifespan. Taken together, pha-
ryngeal pumping and lipofuscin accumulation are age-related but
not age-correlated because they are unaffected by the life-extending
mutations, and should no longer be used as measures of healthspan.
Rate of Decline in Health Parameters with Age. Next, for each long-
lived mutant, we computed the rate of decline in each healthspan
parameter to determine the change in the functional capacity
compared to wild type. A regression curve was fit to the values of
different health parameters for all of the strains as they aged.
Then, we compared the healthspan analysis with the rate of aging
predicted by Gompertz analysis to see whether the lifespan
analysis was sufficient to draw conclusions about the health
changes observed in the aging animals (Tables 1 and 2 and SI
Appendix, Tables S1–S12).
Statistical and model analysis of our healthspan data revealed
that no single equation could account for more than one of the
healthspan assays that were performed. This indicates that dif-
ferent cellular capacities deteriorate at distinct rates in aging
worms. For a treatment or mutation to increase the healthy days,
the rate of decline in different parameters is expected to be
slower than wild type. Our chronological data reveal that the rate
of decline for the long-lived mutants was similar to wild type for
stress resistance, except for eat-2 mutants, which exhibit a faster
rate of decline in all of the health parameters compared to wild
type. None of the long-lived mutants tested slowed down the rate
of decline in stress resistance capacity. In contrast, for movement
compared with wild type chronologically, daf-2, clk-1, and ife-2
slow down the rate of decline.
Next, we reasoned that because all strains exhibit different
mean and maximal lifespan, it is important to evaluate healthspan
if the strains are age-matched. Therefore, we reevaluated all of the
healthspan data by normalizing them to the lifespan of wild type.
This analysis is referred to as “physiological comparison.” In-
terestingly, none of the long-lived mutants slowed down the rate of
decline in different health parameters when measured in an age-
matched population. This indicates that even though proportional
healthspan increase might be possible, the consequence would be
a proportional increase in the frailty period. Notably, the decline
in health status of the different mutant strains occurs much earlier
than predicted by the Gompertz equation. Neither of the two
variables in the Gompertz analysis (A or G) correlated with the
decline in the health parameters tested. This indicated that the
“rate of aging” as predicted by the Gompertz analysis is a measure
similar to lifespan and not a good estimate of either the health of
the population or of the individual animals. Taken together, when
normalized for lifespan, all of the long-lived mutants have an in-
creased frailty period. Therefore, any new method, intervention,
or genetic alternation that alters healthspan should attempt to
decrease the rate of decline physiologically.
Healthspan Versus Gerospan. To get an accurate assessment of the
health of the animals, we suggest that the lifespan of an animal
should be divided into two separate parts: healthspan and gero-
span. Healthspan is defined as the period when the animal has
greater than 50% of the maximal functional capacity of wild type.
Gerospan is defined as the period when the animal has less than
50% of the maximal functional capacity of wild type. Ideally,
a healthy long-lived mutant would exhibit an extension of health-
span and a compression of gerospan. Using these defined terms,
we analyzed all of our healthspan data chronologically, simply
counting the number of days spent in healthspan vs. gerospan for
each mutant in each assay. Defining healthspan as a chronological
function reveals that daf-2 increases the number of healthy days in
almost all of the parameters tested. However, the other long-lived
mutants stayed healthy for a similar number of days as wild type
(Fig. 8). Then, we calculated the gerospan illustrated by the brown
bars (Fig. 8). This analysis reveals that irrespective of the genetic
intervention, the gerospan or frailty period has been extended.
We then normalized the healthspan-to-gerospan ratio to their
maximal lifespan (with the maximal lifespan set to 100%) and
compared the different strains physiologically. As shown in Fig.
9, none of the long-lived mutants show a proportional increase in
healthspan with a reduction in gerospan, indicating that in all
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Fig. 7. Changes in autofluorescence with age (lipofuscin). The bar graph
indicates the changes in autofluorescence as the worms age. The amount of
autofluorescence increased in all of the mutants. Compared with wild type,
both daf-2 and ife-2 mutants show significantly lower accumulation at day 1
and day 15. After day 20, regardless of their mean/maximal lifespan, all of the
strains show similar amounts of lipofuscin accumulation. *P < 0.05.
Table 2. Summary of the rate of decline in different health parameters when strains are
compared chronologically
Genotype Heat stress resistance Oxidative stress resistance Distance moved Thrashing in liquid
daf-2 =WT =WT >WT initially >WT initially
<WT later <WT later
eat-2 <WT initially =WT >WT >WT
>WT later
ife-2 =WT =WT <WT <WT
clk-1 <WT <WT <WT initially >WT initially
>WT later <WT later
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cases lifespan extension does not proportionately increase health-
span. Therefore, these long-lived mutants add onto the frailty time
rather than extending healthspan, indicating that there is a cost to
extending the number of days an organism survives.
We have defined the terms healthspan and gerospan based on
50% of wild type functional capacity. Because this cutoff was ar-
bitrarily defined, we decided to further explore these terms by
setting the cutoff at a later time point: the ratio of healthspan to
gerospan with a cutoff of 30% of wild-type functional capacity (or
when the strains have lost 70% of their functional capacity com-
pared with wild type) (SI Appendix, Figs. S3–S5). This, however,
gave a similar result to the 50% cutoff, indicating that none of the
long-lived mutants result in an extension of healthspan along with
compression of gerospan. Interestingly, when the gerospan cutoff
was set to 30% of wild-type functional capacity, the healthiest
animal is wild type (SI Appendix, Fig. S5). Taken together, our data
suggest that defining healthspan and gerospan with 50% func-
tional capacity of wild type is the best resolution of the data.
Discussion
Previously, the word “healthspan” has been used in many scientific
contexts, but the definition has been ambiguous at best. Therefore,
Fig. 8. Comparison of chronological healthspan vs. gerospan ratio. Healthspan is defined as the period when the animal has greater than 50% of the
maximal functional capacity of wild type. Gerospan is defined as the period when the animal has less than 50% of the maximal functional capacity of wild
type. Comparisons were made by comparing the results for each day and are based on the maximal number of days each strain survives.
Fig. 9. Comparison of physiological healthspan vs. gerospan ratio. Comparisons were made by normalizing the maximal lifespan to 100% for all strains.
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in this study, we focused on providing a conceptual framework of
healthspan that can be easily verified in a laboratory setting using
C. elegans. The current study makes no claim that the healthspan
parameters tested cover all aspects of healthspan, nor does it make
any assumptions that antiaging therapies that extend lifespan can-
not coincide with an increase in healthspan. Rather, we highlight
limitations of aging studies focused solely on lifespan extension.
Here we defined healthspan broadly by testing multiple assays
as the animals aged. We tested wild type as our benchmark and
then compared data from four long-lived mutants with wild-type
health. From these data, we calculated and compared both the
chronological number of days an animal is healthy vs. frail and
the percent of the physiological lifespan the animal spends in
each state (healthspan:gerospan ratio; Figs. 8 and 9).
Our data with the canonical allele of the C. elegans insulin/
IGF-1 receptor homolog daf-2(e1370) reveals that, for multiple
assays, these animals exhibit an increased number of healthy days.
In addition, they increased the number of days spent in a frail
state. When examining these data as a percentage of maximal
lifespan, daf-2 spends a larger proportion of life in a frail state
than wild type (healthspan:gerospan ratio). Analyses of eat-2
mutants, a genetic model for dietary restriction, as well as clk-1
(mitochondrial mutant) show that both mutants extend lifespan
but not healthspan when compared either chronologically or phys-
iologically. In contrast, ife-2 mutants, similar to daf-2 mutants,
increase the number of healthy days in some assays but spend
a longer period of lifespan in a frail state as a consequence.
We also determined the rate of decline (dependent on each
healthspan assay) for wild type as well as the four long-lived
mutants. Our analysis revealed that depending on the health pa-
rameter tested (heat stress resistance, oxidative stress resistance,
movement on plates, movement in liquid), in accordance with
previous reports (27), each healthspan parameter declines with
age at a different rate and this differs among the strains as well.
The rate of change in healthspan parameters with age was also
compared with the rate of aging as calculated by the Gompertz
variable. daf-2, eat-2, and ife-2 mutants decrease the mortality
rate as they age. However, our healthspan analysis suggests that
this decline in the mortality rate does not equate to changes in
health. Moreover, because the rate of mortality is reduced and the
rate of decline in the health parameters is not, the long-lived
mutants do not exhibit a proportional increase in healthspan.
Rather, this results in an expansion of the frailty period or gero-
span, when the data are normalized to maximal lifespan. Together,
our data show that lifespan extension can result in an increased
number of healthy days but that this will also increase the frailty
period as a consequence, which ultimately would have disastrous
economic and social consequences if applied to humans.
Thus far, the reports evaluating the healthspan of the four
long-lived C. elegans mutants analyzed in this study have been
limited. Gerstbrein et al. (29) used autofluorescent accumulation
as a marker of healthspan and showed daf-2(e1370) mutants with
lower levels of autofluorescent accumulation compared with wild
type at day 12. Several other C. elegans studies have noted a vast
number of age-related changes in wild type and some long-lived
mutants (29). Liu et al. (51) examined changes in the neuro-
muscular junction in aging worms and found that two alleles of
daf-2 [daf-2(e1368) and daf-2(1370)] postponed the age-associ-
ated motor activity decline, with daf-2(e1370) showing a longer
protective period. However, any comparisons have been chro-
nological and few studies examined long-lived animals late into
their maximum lifespan. Our study is the first attempt, to our
knowledge, to measure both healthspan and gerospan as defined
by the different measurements and calculate the period of each
as a percentage of lifespan. Based on our analyses, we conclude
that the mutants tested, at their best, are capable of maintaining
a rate of decline in a health parameter similar to wild type. Al-
though this means that a long-lived mutant can have a pro-
portionate increase in healthspan, there will also be an increase
in the frailty period or gerospan as a result of the lifespan ex-
tension. Furthermore, resetting the gerospan threshold to 30%
(i.e., when the animals have lost 70% of maximum wild-type
capacity) suggests that wild type is the healthiest. In agreement
with our results, genetic screens for healthspan mutants based on
prolonged movement at advanced age have not identified any of
the well-known long-lived mutants (31), indicating that the reg-
ulators of healthspan and lifespan thus far may be different.
Our results indicating that the increase in the absolute length
of frailty in long-living mutants may be controversial, although
perhaps not surprising. The antagonistic pleiotropic theory first
proposed by Williams in 1957 states that aging is the result of the
natural selection of many genes with pleiotropic function that
benefit the young but will have an adverse effect later in life.
In agreement with this theory, it has been demonstrated by
different groups that there is a fitness cost in the form of de-
creased fecundity as a result of extending lifespan in both worms
and flies (55, 56). This indicates that healthspan has already been
evolutionarily optimized and supports the idea that changes in
lifespan do come at a measurable cost. Indeed, this has been
found true for the long-lived mutants used in this study, where
each mutant shows a reduced brood size at either normal or high
temperature (57–60). In addition, given that the null phenotype
of daf-2 mutants is embryonic arrest (58), the healthspan results
with daf-2 may not be that unexpected.
It should be noted that we have only examined single mutants.
Each of these strains has been backcrossed a limited number of
times (Materials and Methods). It is still possible that any of these
strains might bear mutations in the background that could con-
tribute to a decrease in healthspan in any of the parameters tested.
Indeed, it is also conceivable that altering multiple pathways could
give rise to healthspan and lifespan extension. Arantes-Oliveira
et al. (61) suggest that healthy long-lived animals arise from the
combination of a mutation in daf-2 (different allele from that used
in this study) with daf-2 RNAi and complete ablation of the germ
line. Chen et al. (62) combined mutation in daf-2 (similar allele to
this study) with mutation in rsks-1, C. elegans S6 kinase to reveal
extreme longevity. However, neither study analyzed the worms in
multiple assays as they aged. Moreover, in both cases, there are
drastic consequences of the lifespan extension: limited or no re-
production. It would be interesting, nonetheless, in future studies
to test these combinations in a similar cross-sectional study.
The potential tradeoff due to increased lifespan may also ex-
tend to mammalian studies. Long-lived dietary-restricted and
IGF-1–deficient mice show health deficits including delayed sex-
ual maturity and reduced fertility along with reduced muscle
strength (63, 64). In addition, dwarf mice eat normally, extend
lifespan by 50%, but become obese and have muscle weakness in
old age, which has an effect on their health. Unfortunately, this is
often ignored because studies in mice often only sample early time
points for comparison (reviewed in ref. 64).
With the older population increasing in numbers, non-
communicable age-related diseases such as heart disease, cancer,
and Alzheimer’s disease are also on the rise (36). However, aging
research has mainly focused on lifespan extension, with limited
focus on determining whether this extension in lifespan comes at
the cost of healthspan. Our data show that although we can in-
crease lifespan and even healthspan in some assays, this also results
in a disproportionate increase in gerospan or the time spent in
a frail state. We suggest that, to improve the quality of life, the
healthspan:gerospan ratio is much more informative than lifespan
extension alone. Altogether, we suggest that to uncover genes and
interventions that would result in healthy aging, research should
shift the focus from lifespan extension to increasing healthspan and
compressing gerospan.
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Materials and Methods
Strain Maintenance. Worms were grown at 15 °C unless otherwise indicated
on standard nematode growth medium (NGM) plates using standard
C. elegans techniques (65). The following strains were used in this study:
MQ130 clk-1(qm30) and KX15 ife-2(ok306), both 10× backcrossed; DA1113
eat-2(ad1113), 2× backcrossed; and CB1370 daf-2(e1370), 5× backcrossed.
Lifespan Analysis. All strains were maintained at 15 °C. For each strain, gravid
adults were isolated and then bleached to isolate eggs. Eggs were then
placed in liquid overnight to obtain a synchronized population of L1 worms
that were then plated and allowed to grow until they developed into young
adults. Approximately 120 young adults worms were transferred onto four
freshly seeded plates supplemented with 5-fluorodeoxyuridine (FuDR) to
a final concentration of 0.1 mg/mL. These plates were then moved to a 20-°C
incubator at day 1. Worms were scored by gently tapping with a platinum
wire every 2–3 d. Worms that crawled off the plate, bagged, or died from
vulval bursting were censored from the analysis. Statistical analyses for
survival were conducted using the standard χ2-based log-rank test. Lifespan
analysis was also repeated on non-FuDR plates (SI Appendix, Fig. S2), where
animals were transferred to new plates every day for the first few days and
then every 2–3 d after the worms had stopped laying eggs.
Healthspan Assays. All strains were maintained at 15 °C. For each strain,
gravid adults were isolated and then bleached to isolate eggs. Eggs were
then placed in liquid overnight to obtain a synchronized population of L1
worms that were then plated and allowed to grow until young adult worms.
Approximately 1,200 young adult worms were picked onto 40 plates con-
taining FuDR (0.1 mg/mL) and then shifted to 20 °C. Every fifth day, one
plate of each strain was taken out for analysis (SI Appendix, Fig. S1). Each of
the assays reported below has been repeated at least twice.
Resistance to Heat Stress. Every fifth day, one plate per strain was removed
from 20 °C and transferred to 37 °C. Every 2 h, the worms were tapped with
a platinum wire and worms that did not respond were scored as dead and
counted. The percentage survival and mean survival was then calculated.
Two biological repeats were done. Statistical analysis for survival was done
using the standard χ2-based log-rank test.
Resistance to Oxidative Stress. One milliliter of paraquat solution (250 mM)
was added onto the top of 30-mm plates. These plates were put on a shaker
for 1 h and then placed in a laminar flow hood for 2 h to completely dry.
Approximately 30–40 worms were picked from the stock plates every fifth
day at 20 °C onto paraquat plates. These plates were then put at 20 °C. Every
2 d, worms were tapped with a platinum wire to count the number of dead
worms. The percentage survival was plotted and mean survival under oxida-
tive stress was calculated. Two biological repeats were done. Statistical anal-
yses for survival were conducted using the standard χ2-based log-rank test.
Locomotion Assays. On solid media plates, 15 worms were picked individually
onto 15 freshly seeded 35-mm NGM plates. After 5 min, the worms were re-
moved and a picture of the tracks made by the worms on the food was taken
with a Nikon Coolpix 995 camera. The average distance covered was calculated
by measuring the traces on the bacterial lawn using the software ImageJ (NIH).
In liquid, every fifth day, 13–15 worms were picked from the stock plates
at 20 °C and transferred to 24-well plates containing 1 mL of M9 solution in
each well. The worms were allowed to equilibrate for ∼30 s, and then the
thrashing was recorded using a Nikon Coolpix 995 camera. The average
thrashings per minute were computed and then plotted for all of the strains.
Pharyngeal Pumping. Worms were observed under the Zeiss Stemi 2000 mi-
croscope with focus on the pharynx. Pharyngeal pumping was calculated for
30 s and then plotted.
Phalloidin Staining. Every fifth day, wormswere washed off the plates withM9
buffer and collected into a microcentrifuge tube to pellet the worms. Phal-
loidin staining was performed using amodified protocol from Costa et al. (66).
Briefly, worm pellets were washed twice with M9 buffer and then fixed using
three freeze/thaw cycles in 2× modified Ruvkun’s witches brew buffer as
described in Yen et al. (67). Worms were then washed once with PBS and then
once with 70% (vol/vol) methanol. Two units of fluorescein-conjugated
phalloidin (Molecular Probes) was added and worm pellets were dried in
a dark room for 2 h. Twenty microliters of S Mix (66) was then added to
dissolve the phalloidin and left to stain at room temperature for 1 h. The
worm pellet was then washed twice with PBS, 0.5% BSA, 0.5% Tween 20. The
stained worms were mounted on slides and observed under a FITC filter using
an Axioskop 2 Plus microscope.
Autofluorescence Measurement. Every fifth day, 10–15 worms were taken and
mounted on a slide. Photos were then taken at 300-ms exposure under a
DAPI filter using an Axioskop 2 Plus microscope. The fluorescence was cal-
culated using ImageJ software.
Statistical Analysis. The log-rank test was used for comparing the survival
curve of various mutants with wild type, and the mean survival time for each
mutant at every fifth day was determined.
Statistical Methods for Calculation of the Rate of Decline in Stress Resistance.
For the first healthspan parameter, homeostatic response to stress (oxi-
dative stress and heat stress experiment), a Cox proportional hazards
model was fit to the survival data using the software R, software for sta-
tistical computation and graphics (68). This analysis was used for the fol-
lowing predictor variables: age, genotype, and the interaction between
age (or normalized age by corresponding median lifespan) and genotype
(68). In addition, we took the variability due to replicate experiments into
account by adding a dummy variable in the model. From this model, the
output is the hazard ratio (rate of hazards relative to wild type) for each
mutant. For our healthspan studies, this ratio refers to the likelihood that
the mutant will die from the stress at a given time compared with wild
type. This model then incorporates different covariates (age and geno-
type) and predicts how the hazard ratio changes in response to the
covariates age and genotype. Because the lifespan survival curve is non-
linear, we used a forward selection method that could include with in-
creasing order of the polynomial term for age and its interaction with
genotype. Then, we used the partial likelihood ratio test and a χ2 test to
determine the best-fit model.
Statistical Methods for Calculation of the Rate of Decline in Movement Capacity.
Using R, a system for statistical computation and graphics, an ANOVA was
performed to assess whether aging and genotype affect distance traveled and
thrashing frequency, andwhether an effect of agingdiffers amonggenotypes.
A linear model was fit to include a randomized complete block design with an
experiment as block effect, age, genotype, and the interaction between age
and genotype. An F test was used to determine the best model fit that would
take into account age, genotype, and their interaction.
Software Used in This Study. Statistical analyses and plotting of the data were
performed using GraphPad Prism 6.0 and Microsoft Excel. NIH ImageJ was
used for quantification of locomotion and fat analyses.
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